# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k143599   
B. Purpose for Submission: New device   
C. Measurand:

Buprenorphine, Amphetamine, Cocaine, Marijuana, Morphine, Opiates, Methamphetamine, Phencyclidine, Benzodiazepines, Barbiturates, Ecstasy, Methadone, Oxycodone and Tricyclic Antidepressants

D. Type of Test: Qualitative immunoassay

# E. Applicant:

Chemtron Biotech, Inc.

# F. Proprietary and Established Names:

Chemtrue Drug Screen Cup Tests Chemtrue Drug Screen Cup Tests with OPI 2000

# G. Regulatory Information:

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>ProductCode</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>Regulation Section</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine</td><td rowspan=1 colspan=1>DJG</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21CFR 862.3650, OpiateTest System</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>Amphetamine</td><td rowspan=1 colspan=1>DKZ</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21CFR 862.3100,Amphetamine Test System</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>DIO</td><td rowspan=1 colspan=1>Class I</td><td rowspan=1 colspan=1>21 CFR 862.3250, Cocaineand metabolites TestSystem</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>Marijuana</td><td rowspan=1 colspan=1>LDJ</td><td rowspan=1 colspan=1>Class I</td><td rowspan=1 colspan=1>21 CFR 862.3870,Cannabinoids Test System</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>DNK</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR 862.3640,Morphine Test System</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>Opiates</td><td rowspan=1 colspan=1>DJG</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR 862.3650, OpiateTest System</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>LAF</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR 862.3610,Methamphetamine TestSystem</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>Phencyclidine</td><td rowspan=1 colspan=1>LCM</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>Unclassified, EnzymeimmunoassayPhencyclidine</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>Benzodiazepines</td><td rowspan=1 colspan=1>JXM</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR 862.3170,Benzodiazepines TestSystem</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>Barbiturates</td><td rowspan=1 colspan=1>DIS</td><td rowspan=1 colspan=1>Class I</td><td rowspan=1 colspan=1>21 CFR 862.3150,Barbiturates Test System</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>Ecstasy</td><td rowspan=1 colspan=1>DJC</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR 862.3610,Methamphetamine TestSystem</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>DJR</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR 862.3620,Methadone Test System</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>DJG</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR 862.3650, OpiateTest System</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>TricyclicAntidepressants</td><td rowspan=1 colspan=1>LFG</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR 862.3910,Tricyclic AntidepressantDrugs Test System</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr></table>

# H. Intended Use:

1. Intended use(s): Refer to Indications for Use below

2. Indication(s) for use:

# Chemtrue Drug Screen Cup Tests

The Chemtrue $^ \mathrm { \textregistered }$ Drug Screen Cup Tests are rapid lateral flow immunoassays for the qualitative detection of Buprenorphine, Amphetamine, Cocaine, Marijuana, Morphine 300, Methamphetamine, Phencyclidine, Benzodiazepines, Barbiturates, Ecstasy, Methadone, Oxycodone and Tricyclic Antidepressants drugs in human urine. The test cut-off concentrations and the compounds the tests are calibrated to are as follows:

<table><tr><td>Analyte</td><td>Abbreviation</td><td>Calibrator</td><td>Cutoff Concentration (ng/mL)</td></tr><tr><td>Buprenorphine</td><td>BUP</td><td>Buprenorphine</td><td>10</td></tr><tr><td>Tricyclic</td><td>TCA</td><td>Nortriptyline</td><td>1000</td></tr><tr><td>Antidepressants Amphetamine</td><td>AMP</td><td>d-Amphetamine</td><td>1000</td></tr><tr><td>Cocaine</td><td>COC</td><td>Benzoylecgonine</td><td>300</td></tr><tr><td>Methamphetamine</td><td>MAMP</td><td>d-Methamphetamine</td><td>1000</td></tr><tr><td>Morphine</td><td>MOR</td><td>Morphine</td><td>300</td></tr><tr><td>Phencyclidine</td><td>PCP</td><td>Phencyclidine</td><td>25</td></tr><tr><td>Marijuana</td><td>THC</td><td>11-nor-Δ9-THC9 COOH</td><td>50</td></tr><tr><td>Benzodiazepines</td><td>BZO</td><td>Oxazepam</td><td>300</td></tr><tr><td>Barbiturates</td><td>BAR</td><td>Secobarbital/Pentobarbital</td><td>300</td></tr><tr><td>Ecstasy</td><td>MDMA</td><td>d,1-Methylenedioxy</td><td>500</td></tr><tr><td></td><td></td><td>methamphetamine</td><td></td></tr><tr><td>Methadone Oxycodone</td><td>MTD OXY</td><td>Methadone Oxycodone</td><td>300 100</td></tr></table>

The Chemtrue $^ \mathrm { \textregistered }$ Drug Screen Cup Tests panel can consist of any combination of the above listed drug analytes.

The tests are intended for prescription and Over-The-Counter (OTC) use.

The tests provide only a preliminary result. A more specific alternative chemical method must be used in order to obtain a confirmed assay result. Gas Chromatography $I$ Mass Spectrometry (GCIMS) or Liquid Chromatography $I$ Mass Spectrometry (LC/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drugs of abuse test result, particularly when preliminary positive results are indicated.

The tests are not intended to differentiate between drugs of abuse and prescription use of Benzodiazepines, Barbiturates, Buprenorphine, Oxycodone and Tricyclic Antidepressants. There are no uniformly recognized cutoff concentration levels for these drugs in urine.

# Chemtrue Drug Screen Cup Tests with OPI 2000

The Chemtrue Drug Screen Cup Tests with OPI 2000 are rapid lateral flow immunoassays for the qualitative detection of Buprenorphine, Amphetamine, Cocaine, Marijuana, Opiates 2000, Methamphetamine, Phencyclidine, Benzodiazepines, Barbiturates, Ecstasy, Methadone, Oxycodone and Tricyclic Antidepressants drugs in human urine. The test cut-off concentrations and the compounds the tests are calibrated to are as follows:

<table><tr><td>Analyte</td><td>Abbreviation</td><td>Calibrator</td><td>Cutoff Concentration (ng/mL)</td></tr><tr><td>Buprenorphine</td><td>BUP</td><td>Buprenorphine</td><td>10</td></tr><tr><td>Tricyclic</td><td>TCA</td><td>Nortriptyline</td><td>1000</td></tr><tr><td>Antidepressants Amphetamine</td><td>AMP</td><td>d-Amphetamine</td><td>1000</td></tr><tr><td>Cocaine</td><td>COC</td><td>Benzoylecgonine</td><td>300</td></tr><tr><td>Methamphetamine</td><td>MAMP</td><td>d-Methamphetamine</td><td>1000</td></tr><tr><td>Opiates 2000</td><td>OPI</td><td>Morphine</td><td>2000</td></tr><tr><td>Phencyclidine</td><td>PCP</td><td>Phencyclidine</td><td>25</td></tr><tr><td>Marijuana</td><td>THC</td><td>11-nor-Δ9-THC9 COOH</td><td>50</td></tr><tr><td>Benzodiazepines</td><td>BZO</td><td>Oxazepam</td><td>300</td></tr><tr><td>Barbiturates</td><td>BAR</td><td>Secobarbital/Pentobarbital</td><td>300</td></tr><tr><td>Ecstasy</td><td>MDMA</td><td>d,1-Methylenedioxy</td><td>500</td></tr><tr><td></td><td></td><td>methamphetamine</td><td></td></tr><tr><td>Methadone Oxycodone</td><td>MTD OXY</td><td>Methadone Oxycodone</td><td>300 100</td></tr></table>

The Chemtrue Drug Screen Cup Tests with OPI 2000 panel can consist of any combination of the above listed drug analytes.

The tests are intended for prescription and Over-The-Counter (OTC) use.

The tests provide only a preliminary result. A more specific alternative chemical method must be used in order to obtain a confirmed assay result. Gas Chromatography I Mass Spectrometry (GCIMS) or Liquid Chromatography I Mass Spectrometry (LC/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drugs of abuse test result, particularly when preliminary positive results are indicated.

The tests are not intended to differentiate between drugs of abuse and prescription use of Benzodiazepines, Barbiturates, Buprenorphine, Oxycodone and Tricyclic Antidepressants. There are no uniformly recognized cutoff concentration levels for these drugs in urine.

3. Special conditions for use statement(s): For in vitro diagnostic use only.

4. Special instrument requirements: Not applicable, as the devices are visually-read single-use devices.

# I. Device Description:

The devices are for use with human urine only. They consist of:

· A test cup with 1 to 13 drug test strips   
· Transport vial, transport bag, and mailing box (for confirmation testing)   
· Package insert (instructions for use)

# J. Substantial Equivalence Information:

1. Predicate device name(s): lnnovacon Spectrum II Test Card with Integrated Cups OnTrak TesTcup $^ \mathrm { \textregistered }$ II Pro 5-AS and OnSite CupKit™ Pro 5-AS

2. Predicate 510(k) number(s):

k061718   
k060896

3. Comparison with predicate:

<table><tr><td colspan="3" rowspan="1">Similarities and Differences</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Device</td><td colspan="1" rowspan="1">Predicate (k061718 and k060896)</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">For the qualitative detection of drugs ofabuse in human urine</td></tr><tr><td colspan="1" rowspan="1">Results</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Qualitative</td></tr><tr><td colspan="1" rowspan="1">Methodology</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Lateral flow, competitive bindingimmunoassay based on the principle ofantigen and antibody immunochemistry.</td></tr><tr><td colspan="1" rowspan="1">Storage</td><td colspan="1" rowspan="1">2 - 30° C untilexpiration date</td><td colspan="1" rowspan="1">k061718: 2  30° C until expiration date;k060896: 15 - 30°C until expiration date</td></tr><tr><td>Intended Users</td><td>Prescription and over the counter users</td><td>Prescription users (k060896); Prescription users, including point-of-care (k061718)</td></tr><tr><td>Cutoffs (ng/mL)</td><td>Buprenorphine  same Barbiturates - same Tricyclic Antidepressants same Opiates 2000  same MDMA - same Methadone - same Oxycodone - same Propoxyphene - not included in device Amphetamine - 1000 Benzodiazepines - 300 Cocaine - 300 Methamphetamine  1000 Phencyclidine - same Marijuana - same</td><td>k061718 Buprenorphine - 10 Barbiturates - 300 Tricyclic Antidepressants - 1000 Opiates 2000 - 2000 MDMA- 500 Methadone - 300 Oxycodone - 100 Propoxyphene - 300 k061718 and k060896 Amphetamine  1000 / 300 Benzodiazepines  300 / 200 Cocaine - 300 / 150 Methamphetamine - 1000 /500 / 300 Phencyclidine - 25 Marijuana - 50</td></tr><tr><td></td><td>Morphine -300</td><td>k060896 Morphine - 300/2000</td></tr><tr><td>Format</td><td>Cup only</td><td>k061718: Cup and Dipcard; k060896: Cup only</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

Design Considerations for Devices Intended for Home Use - Guidance for Industry and Food and Drug Administration Staff

# L. Test Principle:

The Chemtrue $^ \mathrm { \textregistered }$ Drug Screen Cup Tests are rapid lateral flow immunoassays in which drugprotein conjugates in the test device compete with drugs or drug metabolites that may be present in urine. On each test strip, a drug-protein conjugate is added to the test band of the membrane – known as the test region (T), and the anti-drug antibody-colloidal gold conjugate pads are placed at the forward end of the membrane. Monoclonal anti-drug antibodies derived from mice are used on the BUP, AMP, COC, MET, MOR, OPI2000, PCP, THC, BAR, MDMA, MTD, and OXY tests. Monoclonal anti-drug antibodies derived from sheep and mice are used on the TCA and BZO tests. If target drugs are present in the urine specimen below its cut-off concentration, the solution of the colored antibody-colloidal gold conjugates moves along with the sample solution by capillary action across the membrane to the immobilized drug-protein conjugate zone on the test band region. The colored antibodygold conjugates then complexes with the drug-protein conjugates to form visible lines. Therefore, the formation of the visible precipitant in the test band indicates a negative result. If the target drug level exceeds its cut-off concentration, the drug/metabolite antigen competes with drug protein conjugates on the test band region for the limited antibody on the colored drug antibody-colloidal gold conjugate pad. The drug will saturate the limited antibody binding sites and the colored antibody-colloidal gold conjugate cannot bind to the drug-protein conjugate at the test region of the test strip. Therefore, absence of the color band on the test region indicates a preliminary positive result. A band should form in the control region (C) of the devices regardless of the presence of drug in the sample to indicate that the test has been performed properly.

# M. Performance Characteristics (if/when applicable):

Performance characteristics for Buprenorphine (BUP) and Tricyclic Antidepressants (TCA) test strips in cup format were established in k142396, unless otherwise noted. The same BUP and TCA test strips from k142396 are used in the candidate devices.

# 1. Analytical performance:

# a. Precision/Reproducibility:

The precision performance of the test strips of the devices was evaluated using 3 lots and 3 operators. Drug-free (negative) urine samples were analyzed and also spiked to concentrations of $- 5 0 \%$ of cutoff, $- 2 5 \%$ of cutoff, cutoff, cutoff $+ 2 5 \%$ and cutoff $^ +$ $50 \%$ . Each drug concentration was confirmed by GC/MS. Each lot was evaluated by a different operator and results were collected over ten non-consecutive days. Results are summarized below.

<table><tr><td colspan="1" rowspan="2">Drug</td><td colspan="1" rowspan="2">Concentration Tested</td><td colspan="1" rowspan="1">Operator1/ Lot 1</td><td colspan="1" rowspan="1">Operator2/ Lot 2</td><td colspan="1" rowspan="1">Operator3/ Lot 3</td><td colspan="1" rowspan="1">Total ofthe threeoperators</td></tr><tr><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td></tr><tr><td colspan="1" rowspan="6">AMP</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">210/0</td></tr><tr><td colspan="1" rowspan="1">-50% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">-25% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">4/6</td><td colspan="1" rowspan="1">4/6</td><td colspan="1" rowspan="1">6/4</td><td colspan="1" rowspan="1">14/16</td></tr><tr><td colspan="1" rowspan="1">+25% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="1">+50% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="2">Drug</td><td colspan="1" rowspan="2">Concentration Tested</td><td colspan="1" rowspan="1">Operator1/Lot 1</td><td colspan="1" rowspan="1">Operator2/ Lot 2</td><td colspan="1" rowspan="1">Operator3/ Lot 3</td><td colspan="1" rowspan="1">Total ofthe threeoperators</td></tr><tr><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td></tr><tr><td colspan="1" rowspan="6">BAR</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">210/0</td></tr><tr><td colspan="1" rowspan="1">-50% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">-25% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">4/6</td><td colspan="1" rowspan="1">5/5</td><td colspan="1" rowspan="1">5/5</td><td colspan="1" rowspan="1">14/16</td></tr><tr><td colspan="1" rowspan="1">+25% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="1">+50% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="6">BZO</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">210/0</td></tr><tr><td colspan="1" rowspan="1">-50% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">-25% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">7/3</td><td colspan="1" rowspan="1">4/6</td><td colspan="1" rowspan="1">4/6</td><td colspan="1" rowspan="1">15/15</td></tr><tr><td colspan="1" rowspan="1">+25% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="1">+50% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="6">COC</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">210/0</td></tr><tr><td colspan="1" rowspan="1">-50% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">-25% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">4/6</td><td colspan="1" rowspan="1">4/6</td><td colspan="1" rowspan="1">4/6</td><td colspan="1" rowspan="1">12/18</td></tr><tr><td colspan="1" rowspan="1">+25% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="1">+50% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="6">MAMP</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">210/0</td></tr><tr><td colspan="1" rowspan="1">-50% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">-25% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">5/5</td><td colspan="1" rowspan="1">4/6</td><td colspan="1" rowspan="1">5/5</td><td colspan="1" rowspan="1">14/16</td></tr><tr><td colspan="1" rowspan="1">+25% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="1">+50% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="6">MOR 300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">210/0</td></tr><tr><td colspan="1" rowspan="1">-50% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">-25% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">4/6</td><td colspan="1" rowspan="1">5/5</td><td colspan="1" rowspan="1">5/5</td><td colspan="1" rowspan="1">14/16</td></tr><tr><td colspan="1" rowspan="1">+25% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="1">+50% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="6">PCP</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">210/0</td></tr><tr><td colspan="1" rowspan="1">-50% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">-25% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">4/6</td><td colspan="1" rowspan="1">4/6</td><td colspan="1" rowspan="1">4/6</td><td colspan="1" rowspan="1">12/18</td></tr><tr><td colspan="1" rowspan="1">+25% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="1">+50% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="2">Drug</td><td colspan="1" rowspan="2">Concentration Tested</td><td colspan="1" rowspan="1">Operator1/ Lot 1</td><td colspan="1" rowspan="1">Operator2/ Lot 2</td><td colspan="1" rowspan="1">Operator3/ Lot 3</td><td colspan="1" rowspan="1">Total ofthe threeoperators</td></tr><tr><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td><td colspan="1" rowspan="1">Neg/Pos</td></tr><tr><td colspan="1" rowspan="6">MTD</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">210/0</td></tr><tr><td colspan="1" rowspan="1">-50% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">-25% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">6/4</td><td colspan="1" rowspan="1">6/4</td><td colspan="1" rowspan="1">5/5</td><td colspan="1" rowspan="1">17/13</td></tr><tr><td colspan="1" rowspan="1">+25% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="1">+50% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="6">OXY</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">210/0</td></tr><tr><td colspan="1" rowspan="1">-50% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">-25% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">5/5</td><td colspan="1" rowspan="1">3/7</td><td colspan="1" rowspan="1">5/5</td><td colspan="1" rowspan="1">13/17</td></tr><tr><td colspan="1" rowspan="1">+25% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="1">+50% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="6">OPIATES 2000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">210/0</td></tr><tr><td colspan="1" rowspan="1">-50% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">-25% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">5/5</td><td colspan="1" rowspan="1">5/5</td><td colspan="1" rowspan="1">2/8</td><td colspan="1" rowspan="1">12/18</td></tr><tr><td colspan="1" rowspan="1">+25% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="1">+50% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="6">THC</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">210/0</td></tr><tr><td colspan="1" rowspan="1">-50% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">-25% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">5/5</td><td colspan="1" rowspan="1">5/5</td><td colspan="1" rowspan="1">5/5</td><td colspan="1" rowspan="1">15/15</td></tr><tr><td colspan="1" rowspan="1">+25% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="1">+50% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="6">MDMA</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">70/0</td><td colspan="1" rowspan="1">210/0</td></tr><tr><td colspan="1" rowspan="1">-50% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">-25% of cutoff</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">10/0</td><td colspan="1" rowspan="1">30/0</td></tr><tr><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="1">4/6</td><td colspan="1" rowspan="1">5/5</td><td colspan="1" rowspan="1">4/6</td><td colspan="1" rowspan="1">13/17</td></tr><tr><td colspan="1" rowspan="1">+25% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr><tr><td colspan="1" rowspan="1">+50% of cutoff</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/10</td><td colspan="1" rowspan="1">0/30</td></tr></table>

b. Linearity/assay reportable range:

Not applicable. These devices are intended for qualitative use only.

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

Stability: Device stability has been evaluated through accelerated and real-time studies. The real-time studies are ongoing. Protocols and acceptance criteria were described and found to be acceptable. The manufacturer claims that the devices are stable for two years (24 months) when stored at $2 { - } 3 0 ^ { \circ } \mathrm { C }$ .

Quality control: Control materials are not supplied with the devices; however the labeling provides information on how to obtain quality control materials.

d. Detection limit:

See Precision/Reproducibility section in M.1.a above.

e. Analytical specificity:

For each drug, specificity was evaluated by spiking various concentrations of similarly structured drug compounds into drug-free urine. Results are expressed as a minimum concentration of metabolite or compound required to produce a response approximately equivalent to the cutoff concentration of the assay. The percent crossreactivity of those compounds is listed below with the calibrator analyte(s) in bold:

<table><tr><td colspan="1" rowspan="1">Target Drug</td><td colspan="1" rowspan="1">Compound</td><td colspan="1" rowspan="1">ConcentrationEquivalent to theCutoff (ng/mL)</td><td colspan="1" rowspan="1">Cross-Reactivity(%)</td></tr><tr><td colspan="1" rowspan="13">AMP</td><td colspan="1" rowspan="1">d-Amphetamine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Methylenedioxyethylamphetamine(MDEA)</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">d,1-Methamphetamine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Phenylephrine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">d-Methamphetamine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">1-Methamphetamine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">d,1 - Methylenedioxymethamphetamine (MDMA)</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">1-Amphetamine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Ephedrine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Pseudoephedrine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">d/1-Amphetamine</td><td colspan="1" rowspan="1">2500</td><td colspan="1" rowspan="1">40</td></tr><tr><td colspan="1" rowspan="1">d,1-3,4-Methylenedioxyamphetamine(MDA)</td><td colspan="1" rowspan="1">3000</td><td colspan="1" rowspan="1">33</td></tr><tr><td colspan="1" rowspan="1">Phentermine</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="10">BAR</td><td colspan="1" rowspan="1">Secobarbital</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Pentobarbital</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Alphenal</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60</td></tr><tr><td colspan="1" rowspan="1">Amobarbital</td><td colspan="1" rowspan="1">800</td><td colspan="1" rowspan="1">38</td></tr><tr><td colspan="1" rowspan="1">Aprobarbital</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60</td></tr><tr><td colspan="1" rowspan="1">Barbital</td><td colspan="1" rowspan="1">10,000</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Butabarbital</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60</td></tr><tr><td colspan="1" rowspan="1">Butalbital</td><td colspan="1" rowspan="1">3000</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">Cyclopentabarbital</td><td colspan="1" rowspan="1">750</td><td colspan="1" rowspan="1">40</td></tr><tr><td colspan="1" rowspan="1">Phenobarbital</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="20">BZO</td><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Alprazolam</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Alpha-Hydroxyalprazolam</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">300</td></tr><tr><td colspan="1" rowspan="1">Bromazepam</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">2,500</td><td colspan="1" rowspan="1">12</td></tr><tr><td colspan="1" rowspan="1">Clobazam</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">150</td></tr><tr><td colspan="1" rowspan="1">Clonazepam</td><td colspan="1" rowspan="1">10,000</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Clorazepate</td><td colspan="1" rowspan="1">350</td><td colspan="1" rowspan="1">86</td></tr><tr><td colspan="1" rowspan="1">Desalkylflurazepam</td><td colspan="1" rowspan="1">65</td><td colspan="1" rowspan="1">462</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">150</td></tr><tr><td colspan="1" rowspan="1">Estazolam</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60</td></tr><tr><td colspan="1" rowspan="1">Flunitrazepam</td><td colspan="1" rowspan="1">375</td><td colspan="1" rowspan="1">80</td></tr><tr><td colspan="1" rowspan="1">Flurazepam</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">333</td></tr><tr><td colspan="1" rowspan="1">Lorazepam</td><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="1" rowspan="1">Lormetazepam</td><td colspan="1" rowspan="1">7,500</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Midazolam</td><td colspan="1" rowspan="1">900</td><td colspan="1" rowspan="1">33</td></tr><tr><td colspan="1" rowspan="1">Nitrazepam</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">150</td></tr><tr><td colspan="1" rowspan="1">Nordiazepam</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">200</td></tr><tr><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">350</td><td colspan="1" rowspan="1">86</td></tr><tr><td colspan="1" rowspan="1">Triazolam</td><td colspan="1" rowspan="1">1,000</td><td colspan="1" rowspan="1">30</td></tr><tr><td colspan="1" rowspan="3">COC</td><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Cocaine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60</td></tr><tr><td colspan="1" rowspan="1">Cocaethylene</td><td colspan="1" rowspan="1">20,000</td><td colspan="1" rowspan="1">1.5</td></tr><tr><td colspan="1" rowspan="13">MAMP</td><td colspan="1" rowspan="1">d-Methamphetamine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">1-Methamphetamine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">d,1-Amphetamine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Phentermine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">d,1  Methamphetamine</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">d-Amphetamine</td><td colspan="1" rowspan="1">10,000</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1-Amphetamine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Ephedrine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Phenylephrine</td><td colspan="1" rowspan="1">10,000</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">Pseudoephedrine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">3,4- Methylenedioxymethamphetamine (MDMA)</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">d,1- Methylenedioxyethylamphetamine (MDEA)</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">d,1-3,4-Methylenedioxyamphetamine(MDA)</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="9">MOR 300</td><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">6-Acetylmorphine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60</td></tr><tr><td colspan="1" rowspan="1">Diacetylmorphine (Heroin)</td><td colspan="1" rowspan="1">2,000</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">50,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">5,000</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">50,000</td><td colspan="1" rowspan="1">0.6</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Procaine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="2">PCP</td><td colspan="1" rowspan="1">Phencyclidine</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Pheniramine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="4">MTD</td><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Doxylamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="1">Pheniramine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="1">2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;1</td></tr><tr><td colspan="1" rowspan="4">OXY</td><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">0.1</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">0.1</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="12">OPIATES2000</td><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Diacetylmorphine (Heroin)</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">50,000</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">50,000</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">6-Acetylmorphine</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">133</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Normorphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Ethylmorphine</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">133</td></tr><tr><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="5">THC</td><td colspan="1" rowspan="1">11-nor-A'-THC-9-COOH</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">11-nor-Δ8-THC-9-COOH</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">167</td></tr><tr><td colspan="1" rowspan="1">∆ -Tetrahydrocannabinol</td><td colspan="1" rowspan="1">12,000</td><td colspan="1" rowspan="1">0.4</td></tr><tr><td colspan="1" rowspan="1">Cannabidiol</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.05</td></tr><tr><td colspan="1" rowspan="1">Cannabinol</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.05</td></tr><tr><td colspan="1" rowspan="13">MDMA</td><td colspan="1" rowspan="1">d,1 - Methylenedioxymethamphetamine (MDMA)</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">1-Methamphetamine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.5</td></tr><tr><td colspan="1" rowspan="1">Ephedrine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.5</td></tr><tr><td colspan="1" rowspan="1">Pseudoephedrine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.5</td></tr><tr><td colspan="1" rowspan="1">d,1- Amphetamine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.5</td></tr><tr><td colspan="1" rowspan="1">1-Amphetamine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.5</td></tr><tr><td colspan="1" rowspan="1">Phentermine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.5</td></tr><tr><td colspan="1" rowspan="1">d,1- Methamphetamine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.5</td></tr><tr><td colspan="1" rowspan="1">Phenylephrine</td><td colspan="1" rowspan="1">&gt;100,000</td><td colspan="1" rowspan="1">&lt;0.5</td></tr><tr><td colspan="1" rowspan="1">Methylenedioxy ethylamphetamine(MDEA)</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="1" rowspan="1">d,1-3,4-Methylenedioxyamphetamine(MDA)</td><td colspan="1" rowspan="1">15,000</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">d-Methamphetamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">0.5</td></tr><tr><td colspan="1" rowspan="1">d-Amphetamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">0.5</td></tr></table>

The sponsor also evaluated the potential for positive and negative interference from non-structurally related compounds, endogenous compounds, $\mathrm { p H }$ , and specific gravity. The structurally unrelated compounds and endogenous substances study was performed by spiking structurally unrelated compounds and endogenous substances at a concentration of $1 0 0 ~ \mu \mathrm { g / m L }$ into urine samples containing drug a $t \pm 2 5 \%$ of the respective drug cutoff concentrations. The following structurally unrelated substances showed no positive or negative interference in this study:

<table><tr><td rowspan=1 colspan=1>Acetaminophen</td><td rowspan=1 colspan=1>5, 5-Diphenylhydantoin</td><td rowspan=1 colspan=1>Octopamine</td></tr><tr><td rowspan=1 colspan=1>Acetone</td><td rowspan=1 colspan=1>Dopamine</td><td rowspan=1 colspan=1>Oxalic Acid</td></tr><tr><td rowspan=1 colspan=1>Acetylsalicylic Acid</td><td rowspan=1 colspan=1>Erythromycin</td><td rowspan=1 colspan=1>Papaverine</td></tr><tr><td rowspan=1 colspan=1>Amoxicillin</td><td rowspan=1 colspan=1>Estradiol</td><td rowspan=1 colspan=1>Penicillin-G</td></tr><tr><td rowspan=1 colspan=1>Ampicillin</td><td rowspan=1 colspan=1>Estrone</td><td rowspan=1 colspan=1>Perphenazine</td></tr><tr><td rowspan=1 colspan=1>R-(-)-Apomorphine</td><td rowspan=1 colspan=1>Ethanol</td><td rowspan=1 colspan=1>Phenelzine</td></tr><tr><td rowspan=1 colspan=1>L-Ascorbic Acid</td><td rowspan=1 colspan=1>Fenofibrate</td><td rowspan=1 colspan=1>Phenylethylamine</td></tr><tr><td rowspan=1 colspan=1>Aspirin</td><td rowspan=1 colspan=1>Fentanyl</td><td rowspan=1 colspan=1>Prednisone</td></tr><tr><td rowspan=1 colspan=1>Aspartame</td><td rowspan=1 colspan=1>Fotemustine</td><td rowspan=1 colspan=1>Promazine</td></tr><tr><td rowspan=1 colspan=1>Atropine</td><td rowspan=1 colspan=1>Furosemide</td><td rowspan=1 colspan=1>Promethazine</td></tr><tr><td rowspan=1 colspan=1>Baclofen</td><td rowspan=1 colspan=1>Gemfibrozil</td><td rowspan=1 colspan=1>d-Propoxyphene</td></tr><tr><td rowspan=1 colspan=1>Benzocaine</td><td rowspan=1 colspan=1>Guaiacolglyceryl ether</td><td rowspan=1 colspan=1>d,1-Propranolol</td></tr><tr><td rowspan=1 colspan=1>Benzoic Acid</td><td rowspan=1 colspan=1>Gentisic acid</td><td rowspan=1 colspan=1>Pyridoxine</td></tr><tr><td rowspan=1 colspan=1>Carisoprodol</td><td rowspan=1 colspan=1>Hydralazine</td><td rowspan=1 colspan=1>Pyrilamine</td></tr><tr><td rowspan=1 colspan=1>Chloramphenicol</td><td rowspan=1 colspan=1>Hydrocortisone</td><td rowspan=1 colspan=1>Pyrogallol</td></tr><tr><td rowspan=1 colspan=1>Chlordiazepoxide</td><td rowspan=1 colspan=1>3-Hydroxytyramine</td><td rowspan=1 colspan=1>Quinidine</td></tr><tr><td rowspan=1 colspan=1>(+)-Chlorpheniramine</td><td rowspan=1 colspan=1>(+/-)-Isoproterenol</td><td rowspan=1 colspan=1>Quinine</td></tr><tr><td rowspan=1 colspan=1>Chlorpromazine</td><td rowspan=1 colspan=1>Ketamine</td><td rowspan=1 colspan=1>Quinolinic Acid</td></tr><tr><td rowspan=1 colspan=1>Clofibrate</td><td rowspan=1 colspan=1>Meprobamate</td><td rowspan=1 colspan=1>Ranitidine</td></tr><tr><td rowspan=1 colspan=1>Clonidine</td><td rowspan=1 colspan=1>Methapyrilene</td><td rowspan=1 colspan=1>Salicylic Acid</td></tr><tr><td rowspan=1 colspan=1>Cortisone</td><td rowspan=1 colspan=1>Methylphenidate</td><td rowspan=1 colspan=1>Sulfamethazine</td></tr><tr><td rowspan=1 colspan=1>(-)-Cotinine</td><td rowspan=1 colspan=1>Nalidixic Acid</td><td rowspan=1 colspan=1>Sulindac</td></tr><tr><td rowspan=1 colspan=1>Creatine Hydrate</td><td rowspan=1 colspan=1>Naloxone</td><td rowspan=1 colspan=1>Tetracycline</td></tr><tr><td rowspan=1 colspan=1>Cyclobenzaprine</td><td rowspan=1 colspan=1>Naltrexone</td><td rowspan=1 colspan=1>Tetrahydrozoline</td></tr><tr><td rowspan=1 colspan=1>Cyclodextrin</td><td rowspan=1 colspan=1>(+)-Naproxen</td><td rowspan=1 colspan=1>Thiamine</td></tr><tr><td rowspan=1 colspan=1>Cyproheptadine</td><td rowspan=1 colspan=1>Niacinamide</td><td rowspan=1 colspan=1>Thioridazine</td></tr><tr><td rowspan=1 colspan=1>Deoxycorticosterone</td><td rowspan=1 colspan=1>Nicotinic Acid</td><td rowspan=1 colspan=1>Tramadol</td></tr><tr><td rowspan=1 colspan=1>Dextromethorphan</td><td rowspan=1 colspan=1>Nifedipine</td><td rowspan=1 colspan=1>Trifluoperazine</td></tr><tr><td rowspan=1 colspan=1>Diclofenac</td><td rowspan=1 colspan=1>19-Norethindrone</td><td rowspan=1 colspan=1>Tryptamine</td></tr><tr><td rowspan=1 colspan=1>Diflunisal</td><td rowspan=1 colspan=1>Norpropoxyphene</td><td rowspan=1 colspan=1>Tyramine</td></tr><tr><td rowspan=1 colspan=1>4-Dimethyl-aminoantipyrine</td><td rowspan=1 colspan=1>Noscapine</td><td rowspan=1 colspan=1>Zomepirac sodium salt</td></tr><tr><td rowspan=1 colspan=1>Diphenhvdramine</td><td></td><td></td></tr></table>

The following endogenous substances showed no positive or negative interference in this study:

<table><tr><td rowspan=1 colspan=1>Albumin</td><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>Riboflavin</td></tr><tr><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>Sodium Chloride</td></tr><tr><td rowspan=1 colspan=1>Cholesterol</td><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>Uric Acid</td></tr></table>

Evaluation of Specific Gravity and $\mathsf { p H }$ on test results:

To evaluate the effect of pH value on the test results, urine controls a $: \pm 5 0 \%$ of the cutoff value were used. Each control level was adjusted by either 1N NaOH solution or 1N HCl to pH levels of 2.0, 3.0, 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, 8.0 and 9.0. Each test sample was tested in duplicate.

To evaluate the effect of specific gravity, urine controls $a t \pm 5 0 \%$ of the cutoff values were spiked with deionized water or sugar to obtain specific gravities of 1.001, 1.010, 1.015, 1.020, 1.025, and 1.030. Each test sample was tested in duplicate.

The results demonstrated that pH and specific gravity do not affect the results from the device.

f. Assay cut-off:

Characterization of how the device performs analytically around the claimed cutoff concentration appears in the precision section, M.1.a., above.

# 2. Comparison studies:

The sponsor performed a method comparison study comparing performance of the test strips of the cup devices to the GC/MS reference method. For each drug test, at least 40 unaltered positive clinical samples and 40 unaltered negative clinical samples with known GC/MS values were tested. Results are summarized below:

# a. Method comparison with predicate device:

Amphetamine   

<table><tr><td rowspan=2 colspan=1>CandidateDevice Result</td><td rowspan=1 colspan=4>Concentration by GC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>≤ cutoff -50%</td><td rowspan=1 colspan=1>cutoff -50% tothe cutoff</td><td rowspan=1 colspan=1>cutoff tocutoff +50%</td><td rowspan=1 colspan=1>≥ cutoff +50%</td></tr><tr><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>67</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>0</td></tr></table>

Agreement among positives $. = 4 1 / 4 2 = 9 8 \%$ Agreement among negatives $= 8 1 / 8 1 = 1 0 0 \%$ \*Sample contained amphetamine at $1 0 6 1 ~ \mathrm { { n g / m L } }$

Barbiturates   

<table><tr><td rowspan=2 colspan=1>CandidateDevice Result</td><td rowspan=1 colspan=4>Concentration by GC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>≤ cutoff -50%</td><td rowspan=1 colspan=1>cutoff -50% tothe cutoff</td><td rowspan=1 colspan=1>cutoff tocutoff +50%</td><td rowspan=1 colspan=1>≥ cutoff +50%</td></tr><tr><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>28</td></tr><tr><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>44</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Agreement among positives $= 4 0 / 4 0 = 1 0 0 \%$ Agreement among negatives $= 5 5 / 5 5 = 1 0 0 \%$

Benzodiazepines   

<table><tr><td rowspan=2 colspan=1>CandidateDevice Result</td><td rowspan=1 colspan=4>Concentration by GC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>≤ cutoff -50%</td><td rowspan=1 colspan=1>cutoff -50% tothe cutoff</td><td rowspan=1 colspan=1>cutoff tocutoff +50%</td><td rowspan=1 colspan=1>≥ cutoff +50%</td></tr><tr><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Agreement among positives $= 4 0 / 4 0 = 1 0 0 \%$ Agreement among negatives $= 4 9 / 5 0 = 9 8 \%$ \*Sample contained Oxazepam at $2 5 3 ~ \mathrm { { n g / m L } }$

Cocaine   

<table><tr><td rowspan=2 colspan=1>CandidateDevice Result</td><td rowspan=1 colspan=4>Concentration by GC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>≤ cutoff -50%</td><td rowspan=1 colspan=1>cutoff -50% tothe cutoff</td><td rowspan=1 colspan=1>cutoff tocutoff +50%</td><td rowspan=1 colspan=1>≥ cutoff +50%</td></tr><tr><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Agreement among positives $= 4 0 / 4 0 = 1 0 0 \%$ Agreement among negatives $= 4 9 / 5 0 = 9 8 \%$ \*Sample contained benzoylecgonine at $2 9 2 ~ \mathrm { { n g / m L } }$

Ecstasy   

<table><tr><td rowspan=2 colspan=1>CandidateDevice Result</td><td rowspan=1 colspan=4>Concentration by GC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>≤ cutoff -50%</td><td rowspan=1 colspan=1>cutoff -50% tothe cutoff</td><td rowspan=1 colspan=1>cutoff tocutoff +50%</td><td rowspan=1 colspan=1>≥ cutoff +50%</td></tr><tr><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>28</td></tr><tr><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Agreement among positives $= 4 0 / 4 0 = 1 0 0 \%$ Agreement among negatives $= 5 6 / 5 7 = 9 8 \%$ \*Sample contained MDMA at $4 9 8 ~ \mathrm { { n g / m L } }$

Methamphetamine   

<table><tr><td rowspan=2 colspan=1>CandidateDevice Result</td><td rowspan=1 colspan=4>Concentration by GC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>≤ cutoff -50%</td><td rowspan=1 colspan=1>cutoff -50% tothe cutoff</td><td rowspan=1 colspan=1>cutoff tocutoff +50%</td><td rowspan=1 colspan=1>≥ cutoff +50%</td></tr><tr><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Agreement among positives $: = 4 0 / 4 0 = 1 0 0 \%$ Agreement among negatives $= 5 0 / 5 0 = 1 0 0 \%$

Methadone   

<table><tr><td rowspan=2 colspan=1>CandidateDevice Result</td><td rowspan=1 colspan=4>Concentration by GC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>≤ cutoff -50%</td><td rowspan=1 colspan=1>cutoff -50% tothe cutoff</td><td rowspan=1 colspan=1>cutoff tocutoff+50%</td><td rowspan=1 colspan=1>≥ cutoff +50%</td></tr><tr><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Agreement among positives $= 4 0 / 4 0 = 1 0 0 \%$ Agreement among negatives $= 5 0 / 5 0 = 1 0 0 \%$

Morphine 300   

<table><tr><td rowspan=2 colspan=1>CandidateDevice Result</td><td rowspan=1 colspan=4>Concentration by GC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>≤ cutoff -50%</td><td rowspan=1 colspan=1>cutoff -50% tothe cutoff</td><td rowspan=1 colspan=1>cutoff tocutoff +50%</td><td rowspan=1 colspan=1>≥ cutoff +50%</td></tr><tr><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>74</td></tr><tr><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Agreement among positives $= 9 0 / 9 0 = 1 0 0 \%$ Agreement among negatives $= 5 0 / 5 0 = 1 0 0 \%$

Oxycodone   

<table><tr><td rowspan=2 colspan=1>CandidateDevice Result</td><td rowspan=1 colspan=4>Concentration by GC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>≤ cutoff -50%</td><td rowspan=1 colspan=1>cutoff -50% tothe cutoff</td><td rowspan=1 colspan=1>cutoff tocutoff +50%</td><td rowspan=1 colspan=1>≥ cutoff +50%</td></tr><tr><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>31</td></tr><tr><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Agreement among positive $\mathrm { ; = 4 0 / 4 0 = 1 0 0 \% }$ Agreement among negatives $= 5 0 / 5 0 = 1 0 0 \%$

Opiates 2000   

<table><tr><td rowspan=2 colspan=1>CandidateDevice Result</td><td rowspan=1 colspan=4>Concentration by GC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>≤ cutoff -50%</td><td rowspan=1 colspan=1>cutoff -50% tothe cutoff</td><td rowspan=1 colspan=1>cutoff tocutoff +50%</td><td rowspan=1 colspan=1>≥ cutoff +50%</td></tr><tr><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>27</td></tr><tr><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Agreement among positives $= 4 1 / 4 1 = 1 0 0 \%$ Agreement among negatives $= 4 9 / 5 0 = 9 8 \%$ \*Sample contained morphine at $1 1 7 9 \mathrm { n g / m L }$ and codeine at $5 2 2 \mathrm { n g / m L }$

Phencyclidine (PCP)   

<table><tr><td rowspan=2 colspan=1>CandidateDevice Result</td><td rowspan=1 colspan=4>Concentration by GC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>≤ cutoff -50%</td><td rowspan=1 colspan=1>cutoff -50% tothe cutoff</td><td rowspan=1 colspan=1>cutoff tocutoff +50%</td><td rowspan=1 colspan=1>≥ cutoff +50%</td></tr><tr><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Agreement among positives $. = 4 0 / 4 0 = 1 0 0 \%$ Agreement among negatives $= 5 0 / 5 1 = 9 8 \%$ \*Sample contained PCP at $2 4 . 6 \mathrm { n g / m L }$

THC   

<table><tr><td rowspan=2 colspan=1>CandidateDevice Result</td><td rowspan=1 colspan=4>Concentration by GC/MS (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>≤ cutoff -50%</td><td rowspan=1 colspan=1>cutoff -50% tothe cutoff</td><td rowspan=1 colspan=1>cutoff tocutoff+50%</td><td rowspan=1 colspan=1>≥ cutoff +50%</td></tr><tr><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Agreement among positives $= 4 0 / 4 0 = 1 0 0 \%$ Agreement among negatives $= 5 1 / 5 1 = 1 0 0 \%$

b. Matrix comparison: Not applicable. This device is for use with urine samples only.

3. Clinical studies:

a. Clinical Sensitivity: Not applicable

b. Clinical specificity: Not applicable

c. Other clinical supportive data (when a. and b. are not applicable):

A consumer study was performed for all analytes, including BUP and TCA, to evaluate the ability of untrained users to interpret the devices properly when given only the labeling (package insert) provided with the devices. One hundred (100) intended lay-users participated in this study from three (3) intended user sites with GC/MS confirmed urine samples at the following concentrations: negative, $50 \%$ , $7 5 \%$ , $12 5 \%$ and $1 5 0 \%$ of the cutoff. Samples were created by spiking drugs into drugfree urine pool. Each sample was aliquotted into an individual blind-labeled container. Each lay-user was provided with a package insert in English only and one blind-labeled sample for testing.

<table><tr><td rowspan=2 colspan=1>Drug (cutoff inng/mL)</td><td rowspan=2 colspan=1>Cutoff</td><td rowspan=2 colspan=1>Conc. byGC/MS(ng/mL)</td><td rowspan=2 colspan=1>n</td><td rowspan=1 colspan=2>Lay Person Results</td><td rowspan=2 colspan=1>%AgreementWith GC/MS</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=5 colspan=1>AMP (1000)</td><td rowspan=1 colspan=1>-100%</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=3 colspan=1>BAR (300)</td><td rowspan=1 colspan=1>-100%</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

<table><tr><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>100</td></tr></table>

<table><tr><td colspan="1" rowspan="5">BZO (300)</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">225</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">375</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">450</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="5">BUP (10)</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">12.5</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="5">COC (300)</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">225</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">375</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">450</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="5">MDMA (500)</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">375</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">625</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">750</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="5">MET (1000)</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">750</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">1250</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="5">MTD (300)</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">225</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">375</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">450</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="5">MOR 300 (300)</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">225</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">375</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">450</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="5">OPI 2000 (2000)</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">2500</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">3000</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="5">OXY (100)</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">75</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">125</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="5">PCP (25)</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">12.5</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">18.75</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">31.25</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">37.5</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="5">TCA (1000)</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">750</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">1250</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="5">THC (50)</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">37.5</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">90</td></tr><tr><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">62.5</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">75</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr></table>

Consumers were also given surveys on the ease of understanding the package insert instructions and $\ge 9 8 \%$ of the lay users indicated that the device instructions can be easily followed. A Flesch-Kincaid reading analysis was performed on the package inserts and the score revealed a reading grade level of less than 7.

4. Clinical cut-off: Not applicable.

5. Expected values/Reference range: Not applicable.

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.